Inspire Financial Statements From 2010 to 2025

INSP Stock  USD 193.77  8.92  4.83%   
Inspire Medical financial statements provide useful quarterly and yearly information to potential Inspire Medical Systems investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Inspire Medical financial statements helps investors assess Inspire Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Inspire Medical's valuation are summarized below:
Gross Profit
679.8 M
Profit Margin
0.0667
Market Capitalization
5.5 B
Enterprise Value Revenue
6.3753
Revenue
802.8 M
There are currently one hundred twenty fundamental trends for Inspire Medical Systems that can be evaluated and compared over time across competitors. Investors and active traders are advised to confirm Inspire Medical's regular fundamental performance against the performance between 2010 and 2025 to make sure the trends are evolving in the right direction. As of 02/26/2025, Market Cap is likely to grow to about 5.8 B. Also, Enterprise Value is likely to grow to about 5.7 B

Inspire Medical Total Revenue

842.94 Million

Check Inspire Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inspire Medical's main balance sheet or income statement drivers, such as Interest Income of 24.4 M, Depreciation And Amortization of 6.9 M or Interest Expense of 20.9 K, as well as many indicators such as Price To Sales Ratio of 6.53, Dividend Yield of 0.0 or PTB Ratio of 7.6. Inspire financial statements analysis is a perfect complement when working with Inspire Medical Valuation or Volatility modules.
  
Check out the analysis of Inspire Medical Correlation against competitors.

Inspire Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding24 M30.5 M19 M
Slightly volatile
Total Assets848.8 M808.4 M248.3 M
Slightly volatile
Short and Long Term Debt Total25.7 M30 M20.7 M
Slightly volatile
Other Current Liabilities50.6 M48.2 M15.5 M
Slightly volatile
Total Current Liabilities92.9 M88.5 M29.3 M
Slightly volatile
Other Liabilities112.8 K167.9 K87.5 K
Slightly volatile
Property Plant And Equipment Net100 M95.2 M20.1 M
Slightly volatile
Accounts Payable40.6 M38.7 M11.4 M
Slightly volatile
Cash161.1 M150.2 M95 M
Slightly volatile
Non Current Assets Total186.5 M177.6 M33.6 M
Slightly volatile
Non Currrent Assets Other11.9 M11.3 M2.7 M
Slightly volatile
Long Term Debt21.8 M18.2 M16.5 M
Slightly volatile
Cash And Short Term Investments264.8 M445.5 M154.5 M
Slightly volatile
Net Receivables97.7 M93.1 M27.5 M
Slightly volatile
Common Stock Total Equity22.6 K33.4 K14.7 K
Slightly volatile
Long Term Debt Total21.8 M18.2 M16.5 M
Slightly volatile
Liabilities And Stockholders Equity848.8 M808.4 M248.3 M
Slightly volatile
Non Current Liabilities Total24.2 M30.2 M18.5 M
Slightly volatile
Capital Surpluse990.6 M943.4 M327.3 M
Slightly volatile
Inventory84.1 M80.1 M17 M
Slightly volatile
Other Current Assets12.7 M12.1 M3.4 M
Slightly volatile
Other Stockholder Equity544.9 M981 M315.3 M
Slightly volatile
Total Liabilities64.8 M118.7 M44.6 M
Slightly volatile
Property Plant And Equipment Gross114.4 M109 M22.3 M
Slightly volatile
Short and Long Term Debt10.6 M10.6 M7.2 M
Slightly volatile
Preferred Stock Total Equity117.3 M137 M109.2 M
Slightly volatile
Total Current Assets329.9 M630.8 M193.9 M
Slightly volatile
Short Term Debt1.1 M1.2 M3.7 M
Pretty Stable
Common Stock24.9 K34.5 K15 K
Slightly volatile
Property Plant Equipment20.8 M19.8 M6.8 M
Slightly volatile
Net Invested Capital362.7 M689.7 M195.4 M
Slightly volatile
Net Working Capital324.8 M542.3 M175.3 M
Slightly volatile
Capital Stock29.9 K34.5 K25.5 K
Slightly volatile
Other Assets183.8 K193.5 K676.9 K
Very volatile
Non Current Liabilities Other140.6 K148 K988.9 K
Slightly volatile
Capital Lease Obligations17.3 M31.8 M9.7 M
Slightly volatile

Inspire Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income24.4 M23.2 M5.4 M
Slightly volatile
Depreciation And Amortization6.9 M6.5 M1.8 M
Slightly volatile
Selling General Administrative556.1 M529.6 M136.2 M
Slightly volatile
Selling And Marketing Expenses121.1 M115.3 M41.9 M
Slightly volatile
Total Revenue842.9 M802.8 M203.3 M
Slightly volatile
Gross Profit713.8 M679.8 M171 M
Slightly volatile
Other Operating Expenses805.1 M766.7 M223.1 M
Slightly volatile
Research Development119.8 M114.1 M34.9 M
Slightly volatile
Cost Of Revenue129.1 M123 M32.3 M
Slightly volatile
Total Operating Expenses675.9 M643.7 M190.9 M
Slightly volatile
Income Tax Expense5.2 M4.9 M1.6 M
Slightly volatile
Reconciled Depreciation6.9 M6.5 M1.4 M
Slightly volatile

Inspire Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation121.8 M116 M26.3 M
Slightly volatile
Begin Period Cash Flow130.7 M185.5 M85 M
Slightly volatile
Other Cashflows From Financing Activities14.9 M22.6 M12.4 M
Slightly volatile
Depreciation6.9 M6.5 M1.4 M
Slightly volatile
Capital Expenditures41.1 M39.1 M7.9 M
Slightly volatile
End Period Cash Flow146.3 M150.2 M96.1 M
Slightly volatile
Change To Netincome62.1 M59.1 M17.1 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio6.536.872825.4529
Slightly volatile
Days Sales Outstanding43.0842.31450.4042
Pretty Stable
Stock Based Compensation To Revenue0.150.14450.0705
Slightly volatile
Capex To Depreciation3.155.9733.5601
Slightly volatile
EV To Sales6.396.723225.1799
Slightly volatile
Inventory Turnover2.031.53511.9927
Slightly volatile
Days Of Inventory On Hand194238229
Slightly volatile
Payables Turnover3.033.1792.9849
Slightly volatile
Sales General And Administrative To Revenue0.560.510.5624
Slightly volatile
Research And Ddevelopement To Revenue0.140.14220.4547
Slightly volatile
Capex To Revenue0.05120.04870.0332
Pretty Stable
Cash Per Share7.5114.96965.9541
Slightly volatile
Days Payables Outstanding149115127
Slightly volatile
Current Ratio6.757.12775.7991
Slightly volatile
Receivables Turnover5.588.6267.2178
Slightly volatile
Graham Number32.1530.616213.0029
Slightly volatile
Capex Per Share1.381.31450.2778
Slightly volatile
Revenue Per Share28.3226.97297.3963
Slightly volatile
Interest Debt Per Share1.181.010.7818
Slightly volatile
Debt To Assets0.03530.03720.6024
Slightly volatile
Operating Cycle253280280
Slightly volatile
Days Of Payables Outstanding149115127
Slightly volatile
Ebt Per Ebit0.831.621.0375
Pretty Stable
Long Term Debt To Capitalization0.04560.0481.0347
Slightly volatile
Total Debt To Capitalization0.03960.04170.8549
Slightly volatile
Quick Ratio6.46.22245.3597
Slightly volatile
Net Income Per E B T1.10.91541.0067
Pretty Stable
Cash Ratio3.371.69662.9246
Slightly volatile
Days Of Inventory Outstanding194238229
Slightly volatile
Days Of Sales Outstanding43.0842.31450.4042
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.920.69960.8992
Slightly volatile
Fixed Asset Turnover8.018.429419.5683
Pretty Stable
Debt Ratio0.03530.03720.6024
Slightly volatile
Price Sales Ratio6.536.872825.4529
Slightly volatile
Asset Turnover0.850.99310.9563
Slightly volatile
Gross Profit Margin0.650.84680.748
Slightly volatile

Inspire Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap5.8 B5.5 B2.5 B
Slightly volatile
Enterprise Value5.7 B5.4 B2.4 B
Slightly volatile

Inspire Fundamental Market Drivers

Forward Price Earnings86.9565
Cash And Short Term Investments445.5 M

Inspire Upcoming Events

6th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Inspire Medical Financial Statements

Inspire Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Inspire Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Inspire Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Inspire Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-745.2 K-782.5 K
Total Revenue802.8 M842.9 M
Cost Of Revenue123 M129.1 M
Stock Based Compensation To Revenue 0.14  0.15 
Sales General And Administrative To Revenue 0.51  0.56 
Research And Ddevelopement To Revenue 0.14  0.14 
Capex To Revenue 0.05  0.05 
Revenue Per Share 26.97  28.32 
Ebit Per Revenue 0.04  0.05 

Pair Trading with Inspire Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inspire Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inspire Medical will appreciate offsetting losses from the drop in the long position's value.

Moving against Inspire Stock

  0.32MD Mednax IncPairCorr
The ability to find closely correlated positions to Inspire Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inspire Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inspire Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inspire Medical Systems to buy it.
The correlation of Inspire Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inspire Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inspire Medical Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inspire Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Inspire Stock Analysis

When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.